JPMorgan Chase & Co’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.2M Buy
1,584,206
+518,623
+49% +$4.65M ﹤0.01% 1959
2025
Q1
$7.99M Buy
1,065,583
+591,207
+125% +$4.43M ﹤0.01% 2348
2024
Q4
$3.57M Sell
474,376
-102,753
-18% -$773K ﹤0.01% 3005
2024
Q3
$4.39M Sell
577,129
-170,402
-23% -$1.3M ﹤0.01% 2717
2024
Q2
$4.62M Buy
747,531
+478,455
+178% +$2.96M ﹤0.01% 2572
2024
Q1
$1.37M Sell
269,076
-278,461
-51% -$1.41M ﹤0.01% 3377
2023
Q4
$3.28M Sell
547,537
-60,978
-10% -$365K ﹤0.01% 2828
2023
Q3
$4.31M Sell
608,515
-23,000
-4% -$163K ﹤0.01% 2514
2023
Q2
$4.45M Buy
631,515
+31,698
+5% +$223K ﹤0.01% 2561
2023
Q1
$5M Sell
599,817
-194,720
-25% -$1.62M ﹤0.01% 2438
2022
Q4
$9.12M Buy
794,537
+20,334
+3% +$233K ﹤0.01% 1988
2022
Q3
$9.76M Buy
774,203
+225,163
+41% +$2.84M ﹤0.01% 1876
2022
Q2
$5.81M Buy
549,040
+348,759
+174% +$3.69M ﹤0.01% 2289
2022
Q1
$3.26M Buy
200,281
+17,823
+10% +$290K ﹤0.01% 2854
2021
Q4
$2.53M Sell
182,458
-3,625
-2% -$50.2K ﹤0.01% 3074
2021
Q3
$2.67M Sell
186,083
-11,403
-6% -$164K ﹤0.01% 2987
2021
Q2
$3.12M Buy
197,486
+33,518
+20% +$530K ﹤0.01% 2946
2021
Q1
$1.67M Sell
163,968
-16,372
-9% -$167K ﹤0.01% 3348
2020
Q4
$1.34M Sell
180,340
-7,784
-4% -$58K ﹤0.01% 3208
2020
Q3
$722K Sell
188,124
-1,565
-0.8% -$6.01K ﹤0.01% 3231
2020
Q2
$904K Buy
189,689
+33,154
+21% +$158K ﹤0.01% 3063
2020
Q1
$313K Sell
156,535
-265,627
-63% -$531K ﹤0.01% 3524
2019
Q4
$1.46M Sell
422,162
-377,812
-47% -$1.3M ﹤0.01% 2874
2019
Q3
$2.29M Buy
799,974
+501,377
+168% +$1.44M ﹤0.01% 2658
2019
Q2
$1.08M Sell
298,597
-19,532
-6% -$70.9K ﹤0.01% 3022
2019
Q1
$2.59M Sell
318,129
-54,011
-15% -$440K ﹤0.01% 2509
2018
Q4
$3M Sell
372,140
-11,421
-3% -$92.2K ﹤0.01% 2411
2018
Q3
$2.93M Buy
383,561
+355,418
+1,263% +$2.71M ﹤0.01% 2571
2018
Q2
$161K Buy
28,143
+8,416
+43% +$48.1K ﹤0.01% 3912
2018
Q1
$94K Sell
19,727
-1,411
-7% -$6.72K ﹤0.01% 3946
2017
Q4
$104K Buy
+21,138
New +$104K ﹤0.01% 3891
2017
Q3
Sell
-244,613
Closed -$1.36M 4286
2017
Q2
$1.36M Sell
244,613
-6,242
-2% -$34.7K ﹤0.01% 2775
2017
Q1
$2.11M Buy
250,855
+237,466
+1,774% +$1.99M ﹤0.01% 2581
2016
Q4
$85K Buy
+13,389
New +$85K ﹤0.01% 3917
2015
Q4
Sell
-53,901
Closed -$614K 4068
2015
Q3
$614K Sell
53,901
-227,799
-81% -$2.59M ﹤0.01% 2875
2015
Q2
$4.21M Buy
+281,700
New +$4.21M ﹤0.01% 2175
2014
Q4
Sell
-36,520
Closed -$357K 3389
2014
Q3
$357K Buy
36,520
+10,898
+43% +$107K ﹤0.01% 3103
2014
Q2
$326K Buy
25,622
+12,344
+93% +$157K ﹤0.01% 3172
2014
Q1
$140K Buy
+13,278
New +$140K ﹤0.01% 3388
2013
Q3
Sell
-39,595
Closed -$61K 3872
2013
Q2
$61K Buy
+39,595
New +$61K ﹤0.01% 3756